Purpose: To evaluate the performance of a commercial plastic scintillator detector (PSD) for smallfield stereotactic patient-specific quality assurance (QA) measurements using flattening-filter-free beam. Methods: A total of 10 spherical targets [volume range: (0.03 cc-2 cc)] were planned with two techniques: (a) dynamic conformal arc (DCA-10 plans) and (b) volumetric modulated arc therapy (VMAT-10 plans). All plans were generated using Varian Eclipse treatment planning system, and AcurosXB v.13 algorithm in 1.0 mm grid size. Additionally, 14 previously treated cranial and spine SRS plans were evaluated [6 DCA, 8 VMAT, volume range: (0.04 cc-119.02 cc)]. Plan modulation was quantified via two metrics: MU per prescription dose (MU/Rx) and Average Leaf Pair Opening (ALPO). QA was performed on the Varian Edge linear accelerator equipped with HDMLC. Three detectors were used: (a) PinPoint ion chamber (PTW; active volume 0.015 cc), (b) Exradin W1 PSD (Standard Imaging; active volume 0.002 cc), and (c) Gafchromic EBT3 film (Ashland). PinPoint chamber and PSD were positioned perpendicular to beam axis in a Lucy phantom (Standard Imaging); films were placed horizontally capturing the coronal plane. Results: PSD, film, and PinPoint chamber measured average differences of 1.00 AE 1.54%, 1.30 AE 1.69%, and À0.66 AE 2.36%, respectively, compared to AcurosXB dose calculation. As the target volume decreased, PinPoint chamber measured lower doses (maximum À5.07% at 0.07 cc target), while PSD and film measured higher doses (2.87% and 2.54% at 0.03 cc target) than AcurosXB. Film agreed with the benchmark detector PSD by an average difference of 0.31 AE 1.20%, but suffered from larger uncertainty; PinPoint chamber underestimated dose by more than 4% for targets smaller than 0.2 cc. Taking PSD as the measurement standard, DCA plans achieved good QA results across all volumes studied, with an average of À0.07 AE 0.89%; for VMAT plans, PSD measured consistently higher dose (1.95 AE 1.36%) than AcurosXB. Correlation study revealed that plan modulation quantified by both MU/Rx and ALPO correlated significantly with QA results. Conclusion: Among all three detectors, PSD demonstrated superior performances in plans with small fields and heavy modulation. High consistency and low uncertainty made PSD a suitable detector for clinical routine SRS QA. PinPoint chamber should be avoided for targets smaller than 0.2 cc; film dosimetry can be utilized with careful evaluation of its uncertainty bracket. Compared to PSD measurements, AcurosXB calculation demonstrated high accuracy for nonmodulated small fields. The positive correlation between plan modulation and QA discrepancy calls for our attention for clinical SRS plans with high modulation.
INTRODUCTION
Stereotactic radiosurgery (SRS) utilizes small apertures and high dose gradient to treat lesions in the brain and spine. Quality assurance (QA) for SRS plans are challenging, as traditional detectors often yield erroneous results under these extreme conditions. The Farmer-type ion chamber is the traditional standard dosimeter for reference dosimetry, but its relatively large sensitive volume (typically 0.6 cc) is not conducive to measurements of small fields or high dose gradients created by intensity modulation techniques. Micro ion chambers (sensitive volume approximately 0.01 cc) are more suitable for SRS QA, but large dose discrepancies up to 10% still exist for field sizes less than 1 cm. 1 Gafchromic film is another commonly used small field dosimeter, due in large part to its high spatial resolution. Unfortunately, the film measurement process is resource intensive, sensitive to small variations in the film processing procedure, and requires a time delay before readout. 2 Compared to ion chamber and film, plastic scintillator detectors (PSD) offer a promising alternative for small field dose measurement. Recently a commercial PSD became available: the Exradin W1 detector from Standard Imaging, Middleton, WI, USA. 3 Both the scintillator fiber and the sensitive volume of Exradin W1 are composed of acrylic, a near water-equivalent material. 4, 5 This composition ensures minimal dose perturbation in water or water equivalent phantoms. The Exradin W1 also displays other useful response characteristics, including minimal dependence to cumulative dose in a single reading, temperature, energy, dose rate, and incidence angle. [4] [5] [6] [7] [8] These characteristics made it suitable for measuring delivered doses for complex treatment deliveries typically seen in linac-based intensity-modulated SRS.
There are many publications on the dosimetric characteristics of the PSD. [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] Among which, several studies demonstrated that the PSD achieved similar dose response to other widely accepted benchmarks, such as Monte Carlo, Gafchromic films and diamond detectors. 11, 12, 17, 18 The PSD is thus chosen to be the benchmark in our study. However, most of the published literature focused on PSD irradiation with simple static fields, very limited number of studies verified its performance in clinical plans with small apertures or intensity modulation. 19 It is therefore our purpose to evaluate the performance of PSD in clinical SRS plans. By proposing a clinical workflow, this paper investigated the feasibility of a commercial PSD system for routine dose verification over a range of complex treatment deliveries, including cranial and spine SRS.
MATERIALS AND METHODS
The plastic scintillating system has three components: a scintillator detector, an optical fiber that transports light, and a photodiode that converts light to electronic signal. 20 The Exradin W1 PSD used in this study contains a scintillating element with active volume of 1 mm diameter 9 3 mm length, and an acrylic (PMMA) optic fiber with 1 mm diameter core. The biggest challenge for a plastic scintillation system is to account for the Cerenkov radiation produced in the transport optic fiber. Cerenkov radiation is the visible light emitted when charged particles are travelling faster than the speed of light. The length of optical fiber exposed in radiation directly correlates with the amount of Cerenkov radiation produced. 20 These signals act as noise and cause erroneously large readings if not accounted for. A chromic removal method was proposed in literature to retrospectively remove the Cerenkov radiation. 21 Green and blue filters divided the light signal into two channels, where the blue channel is mostly contributed by the Cerenkov radiation. The SuperMAX electrometer (Standard Imaging, Middleton, WI, USA) collects charges from both channels and derives the corrected charge value using a predefined formula. This method has been proven to achieve dosimetric accuracy to within 0.7% from ion chamber readings. 20 
2.A. Treatment planning
All contouring and treatment planning was performed using Eclipse v. 13. Dose was calculated via AcurosXB v.13 in 1.0 mm grid size. In order to systematically evaluate the effect of target size on detector response, a total of 10 artificial spherical targets were created [volume range: (0.03 cc, 2.00 cc)]. For each spherical target, one dynamic conformal arc (DCA) plan and one volumetric modulated arc therapy (VMAT) plan were created using 6X-FFF beam energy and 1400MU/min dose rate. All 20 plans were generated such that at least 99% of the target volumes receive the prescription dose (18 Gy) . Hotspot up to 120% of the prescription dose was allowed. Plan quality was evaluated based on the following metrics:
To evaluate high dose conformity, the conformity index (CI) was used:
where PIV is the volume of the prescription isodose line and TV is the volume of the target.
To evaluate the medium dose conformity, the gradient index (GI) was used:
where TV is the same as above and IV 50% is the volume of the 50% isodose line. In addition to spherical targets, 14 previously treated intracranial and spine SRS plans were included in the evaluation. . In total, our study evaluated 34 cases: 10 spherical target DCA cases, 10 spherical target VMAT cases, and 14 clinical cases (VMAT and DCA combined). The four large spine SRS targets were included to investigate the detector response and dose calculation accuracy in continuous small segmented subfields of heavily modulated plans.
2.B. Plastic scintillator detector calibration
Cerenkov calibration of the PSD was performed using vendor-recommended procedure, with SAD setup in solid water at 2 cm depth. The scintillating light output was measured twice for 40 9 40 cm 2 field size, once with the maximum length of optic fibers in the field and another time with the minimum length. 3 Two parameters were derived from this dual-channel method: the Gain and Cerenkov light ratio (CLR):
Gain ¼ 1 ðSC1 min40 À SC2 min40 Â CLRÞ Where SC1 max 40 was the scintillator channel 1 reading with maximum fiber configuration in 40 9 40 cm 2 ; SC1 min40 was the scintillator channel 1 reading with minimum fiber configuration in 40 9 40 cm 2 ; SC2 max40 was the scintillator channel 2 reading with maximum fiber configuration in 40 9 40 cm 2 ;
SC2 min40 was the scintillator channel 2 reading with minimum fiber configuration in 40 9 40 cm 2 . The Gain and CLR values were subsequently used by the SuperMax electrometer in a mathematical formula to derive the corrected charge for each irradiation.
2.C. Phantom delivery
All plans were delivered on the Varian Edge linac equipped with 6D couch and HDMLC. The Lucy phantom was placed at the end of the treatment couch to minimize beam attenuation through the couch (Fig. 1 ). Prior to delivery, cone-beam CT (CBCT) was utilized to align the phantoms. Measurements were acquired with three different detectors: (a) TN 31014 PinPoint ion chamber (PTW; active volume 0.015 cc), (b) Exradin W1 PSD (Standard Imaging; active volume 0.002 cc), and (c) Gafchromic EBT3 film (Ashland). The PinPoint and PSD were set up in the Lucy phantom (Standard Imaging) perpendicular to the beam axis;
Films were placed horizontally inside the Lucy phantom, capturing the coronal plane. For each detector, the measurements were repeated three times, each time with an independent setup on a different day. The three readings were then averaged and recorded.
2.D. Film calibration
Calibration films were placed at 5 cm depth (100 cm SAD) in solid water (30 9 30 9 11 cm 3 , Gammex Inc., Middleton, WI, USA), as shown in Fig. 1 . An in-house film dosimetry protocol was developed to convert optical density to dose. 25 Calibration films were irradiated in a nine square dose pattern (area of 2 9 2 cm 2 per square), with doses ranging from 3.2 Gy to 24.2 Gy. The in-house calibration routine matches the film optical densities within each square to the calculated dose. A calibration curve was generated for each color channel using cubic polynomial least squares fitting. Films were scanned in an Epson Expression 10000XL document flatbed scanner (Seiko Epson Corp, Nagano, Japan). Resolution settings of 150 dot per inch and 48 bit RGB mode (16 bits per color channel) were employed. The average delay time before scanning was approximately 24 h in our protocol. All films were scanned at the center of the scanner bed. A 4-way flip method was employed to average out any intrinsic light source non-uniformity of the scanner. Dosimetric analysis was done via green channel due to its superior sensitivity at doses higher than 10 Gy. The percentage difference between film and planned dose at isocenter was recorded.
2.E. Plan delivery modulation quantification
Plan modulation was quantified by two metrics: MU per prescription dose (MU/Rx), and Average Leaf Pair Opening (ALPO). ALPO is the weighted average of all leaf pair openings at each control point: for each leaf pair, the opening is multiplied by the number of MUs delivered for that control point. 26 
2.F. Uncertainty analysis
The uncertainty associated with the data presented in this work was estimated using error propagation from both type A and B uncertainties. 27 Type A uncertainty was estimated from the repeated measurements taken for each detector, characterizing the repeatability of MU delivery and charge collection of the detectors. Type B uncertainty was calculated as the root mean square of the total square uncertainties associated with image registration (AE0.5 mm), couch movement accuracy (AE0.5 mm), and the calibration procedures.
RESULTS
The treatment planning parameters and dose metrics for the spherical target planning are summarized in Table I . As expected, VMAT demonstrated higher plan modulation than DCA. In Table I ALPO ðcmÞ ¼
Medical Physics, 44 (10) , and averaged ALPO of 1.24 cm. All spherical and clinical plans achieved similar hotspots, with the maximum dose ranging from 116% to 120% of the prescription dose.
The QA results, i.e., percent difference between measured and calculated dose, were compiled in Table III . For each target, the readings were averaged from three independent setups. Film revealed higher uncertainty (average st.dev. 1.93%) than the other two detectors (PinPoint average st.dev. 0.71%; PSD average st.dev. 0.62%), attributing to its higher type B uncertainty. Table IV listed the contributing components of the uncertainty analysis for a typical plan; type A and B uncertainties were also defined for each component. It was revealed that neither type A or B dominated the uncertainty analysis. As the target volume decreased, type B uncertainty increased slightly, contributing to a higher overall standard deviation.
QA results listed in Table III were also plotted in Fig. 2 
. Discrepancies started to increase with decreasing target volumes. As the target volume becomes smaller, the PinPoint chamber measured lower doses (min À3.97% at 0.03 cc) than AcurosXB, while the PSD and film measured higher doses (max 2.48% at 0.03 cc). For VMAT plans [ Figs. 2(b) and 2(d) ], PinPoint chamber continued to suffer from volume averaging effect at small fields (min À5.07% at 0.07 cc). However for PSD and film, their results did not correlate with target volume like DCA plans did. Instead, PSD and film measured a consistent higher dose of 1.74 AE 0.75% and 2.41 AE 1.15% than AcurosXB, as shown in Fig. 2(b) , and 2.27 AE 2.24% and 2.29 AE 1.70% higher than AcurosXB, as shown in Fig. 2(d) .
The interdetector differences were plotted against target volumes in Fig. 3 . Of the three detectors, film and PSD achieved good agreement across the range of volumes studied, with an average difference of 0.49 AE 0.92% for DCA, and 0.15 AE 1.41% for VMAT. PinPoint chamber readings deviated from PSD as the target volume decreased. The maximum difference between PSD and pinpoint chamber occurred at 0.03 cc for DCA (À4.82%) and 0.07 cc for VMAT (À6.89%). The effect of plan modulation on QA discrepancy was investigated for all targets, and plotted in Figs. 4 and 5. Plan modulation was quantified using two metrics in this study: MU per prescription dose and ALPO. QA discrepancy was defined as the percentage difference between PSD measurement and AcurosXB calculation. In Fig. 4 , linear fitting revealed a correlation of R = 0.73 between MU per prescription dose and QA discrepancy. Four cases of spine SRS were plotted but excluded from the line fitting due to their much larger target volumes (18.75-119.02 cc). Our hypothesis was that the large spine volumes induced much wider leaf openings compared to brain SRS, contributing to better QA agreements. Figure 5 plotted QA results against ALPO for all targets. Linear correlation study confirmed our hypothesis (R = 0.62), indicating a moderate correlation between the averaged leaf openings and QA discrepancy.
DISCUSSION
Accurate dosimetric verification is of paramount importance in stereotactic radiosurgery. In order to verify the treatment planning dose calculations, a reliable detector is needed for patient specific QA. Micro ion chamber and film have been standard dosimeters for SRS QA in our clinic. However, for small targets or heavily modulated plans, it is often challenging to achieve good agreement between calculation and measurement. There are two major drawbacks relating to the use of ion chamber for small field measurement: (a) the volume averaging effect 28 and (b) perturbation of the radiation field in the vicinity of the point of measurement. 28, 29 In small fields, the high gradient across the chamber volume contributes to a lower averaged reading than the predicted value. This effect is evident in Fig. 2 , where the Pinpoint chamber measured significantly lower dose than AcurosXB as the target size decreased. The superior spatial resolution of Gafchromic film is favorable in small field dosimetry. Gafchromic film employed in this study is known for its water equivalence, independence of energy, dose rate, field size, and incidence angle. However, the calibration process is labor intensive, and the intrinsic differences among films of the same batch also introduced uncertainties on the order of 2%. 30 With these known detector limitations, it can be difficult to make clinical decisions based on either set of measurements. In our study, we noted deviations up to 9% between Pinpoint chamber and film measurements at extremely small targets or high plan modulation (Fig. 2) . A third detector is thus desired for interdetector comparison, as well as dose calculation evaluation.
The Lucy phantom was preferred in this study due to its spherical shape, easy setup, and independence of couch attenuation. CT images were acquired with each detector in their respective insert in the Lucy phantom, and subsequently used for dose calculation. The orientation of PSD and PinPoint chamber was chosen perpendicular to the beam axis in order to avoid oblique entrance. Both detectors' angular dependency in the setup was characterized prior to the study, and confirmed to be within 1% throughout the range of gantry rotation. Although the reported oblique dependency for plastic scintillators can be up to 2%, 8 routine clinical QA avoided such uncertainty by employing only coplanar beams.
Taking PSD as the benchmark, the interdetector differences were plotted against target size in Fig. 3 . Film agreed within 3% to PSD, with an average difference of 0.31 AE 1.20%. This is expected as both detectors exhibit high spatial resolution and minimal dose perturbation in small fields. Film data had a larger average spread (st.dev. 1.03%) than PSD (st.dev. 0.38%) from the three repeated measurements, attributing mainly to the intrinsic film uncertainties. 31 Unlike PSD and film, the PinPoint chamber exhibited a strong relationship with field size. This made sense as the PinPoint chamber has an active volume of 0.015 cc, a considerable fraction to the smallest target volume studied (0.03 cc). The volume averaging effect is evident for targets smaller than 0.2 cc, as the PinPoint chamber measured dose more than 5% lower than the calculation and the other two detectors. Compared to DCA, VMAT plans induced more volume averaging in the PinPoint chamber, attributing to the additional MLC modulation. It is therefore dangerous to rely on micro-ion chamber alone for small field complex SRS QA.
In addition to detector behaviors, it was also our interest to investigate the accuracy of dose calculation in this study. Taking PSD as standard, AcurosXB calculation was consistently lower (average À1.95%) than measurements for VMAT plans the worse the agreement between calculation and measurement. MU/Rx is a simpler metric, but it failed to explain the superior QA results in highly modulated spine cases (0.73% for spine versus 2.29% for cranial). The superior agreement in these large spine targets proved that high plan modulation itself does not warrant small field calculation discrepancies. Despite of the small subfields at each control point, the overall composite beam achieved accurate dose calculation. Our second metric ALPO considers both modulation and field size effect. The correlation between ALPO and QA results indicated the possibility of utilizing ALPO as a screening metric for potential problematic SRS QA cases.
CONCLUSIONS
By proposing a clinical workflow to incorporate the W1 PSD into stereotactic radiosurgery QA deliveries, this study investigated PSD's performance in comparison with PinPoint chamber and Gafchromic film. The PSD demonstrated high consistency and small error margin throughout the volumes studied, proving to be a reliable tool for clinical SRS QA. PinPoint chamber should be avoided for targets smaller than 0.2 cc; film dosimetry should not be used without detailed uncertainty analysis.
Taking PSD measurement as the benchmark, AcurosXB was proven accurate for nonmodulated small fields DCA plans. VMAT plans revealed positive correlations between calculation discrepancy and plan modulation. MU/Rx and ALPO, the two metrics quantifying plan modulation in this study, are potentially helpful for troubleshooting clinical SRS QA discrepancies.
